· Highlights
o
India and Japan signed a Memorandum
of Cooperation (MoC) with an investment of $10 billion in AI, semiconductors,
clean energy, and economic security.
o
Carlsberg has filed draft papers with
SEBI for an IPO through the confidential route.
o
CSM Technologies IPO listed on the
stock exchanges at the issue price and closed 5% down at the end of the day
· Stocks Updates
o
Adani Enterprises: signed an MoU with
the Odisha government for an $11.5 billion (around Rs 1.08 lakh crore)
aluminium project through a 50:50 JV with IHC Group’s International Resources
Holding.
o
Kotak Mahindra: acquired a loan
portfolio worth Rs 9,587.62 crore from its wholly-owned subsidiary Kotak
Mahindra Investments Ltd as part of group simplification and RBI compliance.
o
Varun Beverages: South Africa
subsidiaries Beverage Company Proprietary Ltd (Bevco) and Twizza Proprietary
Ltd approved the merger of Twizza into Bevco, subject to local laws.
o
Samvardhana Motherson: indirect
wholly owned subsidiary Motherson DRSC Automotive Product Trading (Shanghai) Co
Ltd was dissolved following voluntary closure. The company said the dissolution
has no material financial impact.
o
Tech Mahindra: subsidiary Tech Mahindra
Servicos De Informatica acquired 100% stake in Brazil-based Alyis Servicos
Tecnicos for BRL 1.2 million (around Rs 2.21 crore).
o
Max Healthcare: received no-objection
letters from BSE and NSE for the reclassification of Radiant Life Care Hospital
Foundation from 'Promoter Group' to 'Public' category, effective immediately.
o
Lupin: received US FDA inspection
report for its Somerset, New Jersey facility with Voluntary Action Indicated
(VAI) classification. This was following an inspection conducted in April.
o
Lenskart: board approved the merger
of wholly owned subsidiaries Dealskart Online Services and Lenskart Eyetech
into the company to simplify its corporate structure and improve operational
efficiencies. It also approved a 80:20 joint venture with China's Mingfeng
Glassesworld Ltd to manufacture metal spectacle frames in India.
o
Aurobindo Pharma: completed the
transfer of its domestic branded generic pharmaceutical formulations business
to wholly owned subsidiary Auropharm Ltd on a slump sale basis.
